No profile data available.
Scholar Rock Holding Corporation (SRRK) is a healthcare company in the brain and nerve treatment drugs industry, based in Cambridge, United States, with about 289 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$377.94 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $5.14 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.
Scholar Rock Holding reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$5.14 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Praxis Precision Medicines, Inc. (PRAX), Alkermes plc (ALKS), PTC Therapeutics, Inc. (PTCT), Dianthus Therapeutics, Inc. (DNTH).